Letters to the Editor

Carbon footprint of direct oral anticoagulants in atrial fibrillation and venous thromboembolism

Pharmacy department, Groupe Hospitalier UNEOS, Metz-Vantoux, France; The Shifters association, Cercle Thematique Sante, Paris
The Shifters association, Cercle Thematique Sante, Paris, France; SESAME, One Health Medical Education, Prades-le-Lez
The Shifters association, Cercle Thematique Sante, Paris, France; Pharmacy department, Centre Hospitalier Universitaire de Rennes, Rennes
The Shifters association, Cercle Thematique Sante, Paris, France; Department of infectious disease, St Nazaire Hospital, Saint-Nazaire
Sorbonne Universite, ACTION Study Group, INSERM UMRS 1166, Institut de Cardiologie, Hopital Pitie-Salpetriere (AP-HP), 47 boulevard de l’Hopital, Paris 75013
The Shift Project, Paris
Ecovamed, Paris
Department of Internal Medicine, Centre Hospitalier Universitaire de La Timone, Marseille
The Shifters association, Cercle Thematique Sante, Paris, France; Hematology Department, Hopital europeen Georges Pompidou, Assistance Publique Hopitaux de Paris-Centre Universite Paris Cite (APHP-CUP), F-75015, Paris, France; Paris Cite University, INSERM, Paris Cardiovascular Research Centre, Team Endotheliopathy and Hemostasis disorders, Paris, France; Investigation Network on Venous Thrombo-Embolism–French Clinical Research Infrastructure Network, Saint-Etienne
Haematologica Early view Dec 11, 2025 https://doi.org/10.3324/haematol.2025.300204